Uracil → HCID 21121131, 화합물

반응식

[CH3:1][N:2]1[C@H:16]2[C@@H:6]([C:7]3[CH:8]=[CH:9][CH:10]=[C:11]4[C:17]=3[C:14]([CH2:15]2)=[CH:13][NH:12]4)[CH2:5][C@@H:4]([CH2:18][N:19]2[CH2:23][C:22](=[O:24])[NH:21][C:20]2=[O:25])[CH2:3]1.N1C=CC(=[O:32])NC1=O>>[CH3:1][N:2]1[C@H:16]2[C@@H:6]([C:7]3[CH:8]=[CH:9][CH:10]=[C:11]4[C:17]=3[C:14]([CH2:15]2)=[CH:13][NH:12]4)[CH2:5][C@@H:4]([CH2:18][N+:19]2([O-:32])[CH2:23][C:22](=[O:24])[NH:21][C:20]2=[O:25])[CH2:3]1

참가 물질

반응물 2

HCID 1174Uracil

HCID 125720Fce 22716

생성물 1

HCID 21121131HCID 21121131, 화합물수율 63%

실험 절차

Repeating Example 1 but using 1-[(6-methylergolin -8β- yl)methyl]-2,4-imidazolidinedione instead of 1-[(6-methyl -Δ- 9,10-ergolen -8β- methyl]-2,4-(1H,3H)-pyrimidinedione the title compound was obtained in 63% yield, m.p. 163-165° C.

출처 및 근거

ORD 기록: ord-57bb00a1b2934812b0df201207b39347
출처 데이터셋: uspto-grants-1989_08
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US04859678

반응 노트

불러오는 중…